- February 15, 2018Bioinformatics Approach Forms the Basis of Inflammatix’s HostDx™ Sepsis Test Burlingame, Calif., February 15, 2018 — Inflammatix announced findings from a…
- December 19, 2017BURLINGAME, Calif., Dec. 19, 2017 /PRNewswire/ — Inflammatix, a molecular diagnostics company that is developing rapid tests that read the immune system to…